Rationale for cholesteryl ester transfer protein inhibition
B Hewing, EA Fisher - Current opinion in lipidology, 2012 - journals.lww.com
B Hewing, EA Fisher
Current opinion in lipidology, 2012•journals.lww.comRationale for cholesteryl ester transfer protein inhibition : Current Opinion in Lipidology
Rationale for cholesteryl ester transfer protein inhibition : Current Opinion in Lipidology Log in
or Register Subscribe to journalSubscribe Get new issue alertsGet alerts Secondary Logo
Journal Logo Advanced Search Toggle navigation Subscribe Register Login Articles & Issues
For Authors Journal Info Advanced Search August 2012 - Volume 23 - Issue 4 Previous Article
Next Article HYPERLIPIDAEMIA AND CARDIOVASCULAR DISEASE: Edited by Paul N …
Rationale for cholesteryl ester transfer protein inhibition : Current Opinion in Lipidology Log in
or Register Subscribe to journalSubscribe Get new issue alertsGet alerts Secondary Logo
Journal Logo Advanced Search Toggle navigation Subscribe Register Login Articles & Issues
For Authors Journal Info Advanced Search August 2012 - Volume 23 - Issue 4 Previous Article
Next Article HYPERLIPIDAEMIA AND CARDIOVASCULAR DISEASE: Edited by Paul N …
Summary
The two ongoing outcome trials, dal-OUTCOMES (dalcetrapib) and REVEAL (anacetrapib), will provide more conclusive answers for the concept of reducing cardiovascular risk by raising HDL-C with CETP inhibition.
Lippincott Williams & Wilkins